NCT00396643 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Berger GE, Proffitt TM, McConchie M, et al
Ethyl-Eicosapentaenoic acid in first episode psychosis: A randomized, placebo-controlled trial. Journal of Clinical Psychiatry 2007; in press Berger GE, Wood SJ, Wellard RM, et al. In vivo brain effects of ethyl-eicosapentaenoic acid in early psychosis. A 1H-MRS study. Neuropsychopharmacology 2007;in press.

Indicated Prevention With Omega-3 Fatty Acids in Adolescents With 'At-Risk-Mental-State' for Psychosis: A Randomised, Double Blind, Placebo-Controlled Treatment Trial

Details for clinical trial NCT00396643

Clinical trial NCT00396643 - References